by MM360 Staff | Sep 19, 2025 | Myeloma News
Source: Pharmacy Times – Pharmacy Practice News and Expert Insights articles Post Content Read More
by MM360 Staff | Sep 19, 2025 | Myeloma News
Source: Pharmacy Times – Pharmacy Practice News and Expert Insights articles Post Content Read More
by MM360 Staff | Sep 19, 2025 | Myeloma News
Source: Pharmacy Times – Pharmacy Practice News and Expert Insights articles Post Content Read More
by MM360 Staff | Sep 18, 2025 | Myeloma News
Source: Pharmacy Times articles An expert discusses the promising results of elranatamab as a consolidative therapy for relapsed/refractory multiple myeloma, enhancing patient outcomes. Read More
by MM360 Staff | Sep 18, 2025 | Myeloma News
Source: Pharmacy Times articles An expert discusses CAR T therapy’s potential in treating relapsed multiple myeloma, highlighting long-term remissions and access challenges. Read More
by MM360 Staff | Sep 17, 2025 | Myeloma News
Source: Pharmacy Times articles Cutting-edge insights and expert discussions on multiple myeloma will be presented at the 2025 IMS Annual Meeting in Toronto, shaping future treatment standards. Read More
